| ASSET | YEAR | % RETURN |
|---|---|---|
Vertex Pharmaceuticals (VRTX) | 2008 | 30.67% |
Vertex Pharmaceuticals (VRTX) | 2009 | 41.54% |
Vertex Pharmaceuticals (VRTX) | 2010 | -18.25% |
Vertex Pharmaceuticals (VRTX) | 2011 | -5.65% |
Vertex Pharmaceuticals (VRTX) | 2012 | 23.89% |
Vertex Pharmaceuticals (VRTX) | 2013 | 73.31% |
Vertex Pharmaceuticals (VRTX) | 2014 | 60.39% |
Vertex Pharmaceuticals (VRTX) | 2015 | 4.88% |
Vertex Pharmaceuticals (VRTX) | 2016 | -40.12% |
Vertex Pharmaceuticals (VRTX) | 2017 | 101.34% |
Vertex Pharmaceuticals (VRTX) | 2018 | 10.47% |
Vertex Pharmaceuticals (VRTX) | 2019 | 35.82% |
Vertex Pharmaceuticals (VRTX) | 2020 | 7.31% |
Vertex Pharmaceuticals (VRTX) | 2021 | -7.7% |
Vertex Pharmaceuticals (VRTX) | 2022 | 32.24% |
Vertex Pharmaceuticals (VRTX) | 2023 | 40.98% |
Vertex Pharmaceuticals (VRTX) | 2024 | -0.57% |
Vertex Pharmaceuticals (VRTX) | 2025 | -4.97% |
